2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Abstract Number: 1542

Metabolic Syndrome and Cardiovascular Risk Factors in Brazilian Patients with Established Rheumatoid Arthritis
Abstract Number: 1543

Obese Patients with RA Have a More Seropositive and a More Active Disease with Less Deformities
Abstract Number: 1544

Serum Omentin-1 Levels and Metabolic Syndrome in Women with Rheumatoid Arthritis
Abstract Number: 1545

Vitamin D Insufficiency in Patients with Rheumatoid Arthritis and Healthy Controls and Correlation Between Vitamin D Levels and Disease Activity and Disability in RA Patients
Abstract Number: 1546

Clinical Features at the Onset of Lymphoproliferative Disorder in Patients with Rheumatoid Arthritis
Abstract Number: 1547

Antibodies Against Carbamylated Proteins in Belgian RA Patients and in Other Rheumatic Diseases
Abstract Number: 1548

Correlates of Fatigue in People Living with Rheumatoid Arthritis
Abstract Number: 1549

Rheumatoid Arthritis and Periodontal Disease: Salivary ACPA Levels and Clinical Presentation
Abstract Number: 1550

Comorbidities of Rheumatoid Arthritis: Results from the Korean National Health and Nutrition Examination Survey
Abstract Number: 1551

Rheumatoid Arthritis Is Associated with Low-/Mid-Frequency Hearing Impairment: Data from the Korean National Health and Nutrition Examination Survey
Abstract Number: 1552

The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from French Cohort Study of Comorbidities
Abstract Number: 1553

Declining Flare Rates in the First Five Years of RA Disease, but Not after
Abstract Number: 1554

Longitudinal Trajectories of the Weighted Lansbury Articular Indices and Standard Joint Counts Are Similarly Correlated with Trajectories of Physical Function in Early Inflammatory Arthritis
Abstract Number: 1555

E-Comorbidity: Evaluation of the Validity of Electronic Comorbidity Assessment in Identifying Comorbid Conditions Among Patients with Rheumatoid and Psoriatic Arthritis
Abstract Number: 1556

Assessment of the Burden of Comorbidities By the Rheumatic Disease Comorbidity Index in Early Rheumatoid Arthritis Patients at Disease Onset

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].